Testicular lymphoma with bone/bone marrow metastases illustrated by scrotal sonography, spinal MRI, and total body Tc-99m HMDP and tc-99m MIBI imagines

Annals of Nuclear Medicine

Volumn 13, Issue 5, 1999, Pages 293-297

  Shih, Wei Jen ^a   Kwolek, Deborh S ^b   Lahr, Barbara ^b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Bone marrow metastases; MRI; Non Hodgkin's lymphoma B cell type; Sonography; Tc 99m MIBI imaging; Tc99m HMDP bone imaging; Testicular mass

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OXIDRONATE TECHNETIUM TC 99M;

AGED; ARTICLE; BONE MARROW METASTASIS; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; ECHOGRAPHY; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCROTUM; TESTIS CANCER; WHOLE BODY SCINTISCANNING;

EID: 0032707296     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03164866     Document Type: Article

References (15)

1. Lu G, Shih W-J, Huang H-Y, et al. Tc-99m MIBI mammoscintigraphy of breast masses: early and delayed imaging. Nucl Med Commun 16: 150-156, 1995.
2. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 178: 491-497, 1994.
3. Burak Z, Argon M, Memis A, et al. Evaluation of palpable breast masses with Tc-99m MIBI: A comparative study with mammography and ultrasonography. Nucl Med Commun 15: 604-612, 1994.
4. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 33: 313-318, 1992.
5. Lu G, Shih W-J, Xiu J-Y. Tc-99m MIBI uptake in recurrent parathyroid carcinoma and brown tumors. J Nucl Med 36: 811-813, 1995.
6. O'Driscoll CM, Baker F, Casey MJ, et al. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxybutylisonitrile scintigraphy: a case report. J Nucl Med 32: 2281-2283, 1991.
7. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxyisobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 14: 333-340, 1989.
8. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: Preliminary results and comparison with Tl-201. Clin Nucl Med 17: 171-176, 1992.
9. O'Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumor with hexakis (methoxyisobutylisonitrile) technetium (I). J Nucl Med 31: 2040-2041, 1990.
10. Shih WJ, Kadzielawak K, Lee C, Moody EB, Ryo UK. Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma. Clin Nucl Med 18: 887-890, 1993.
11. Medolago G, Virotta G, Piti A, et al. Abnormal uptake of technetium-99m hexakis-2-methoxyisobutyl isonitrile in a primary cardiac lymphoma. Eur J Nucl Med 199: 222-225, 1992.
12. Wakasugi S, Teshima H, Nakamura H, Hashizume T, Maeda T, Hiraoka A, et al. Tc-99m MIBI localization in bone marrow: A marker of bone marrow malignancy. Clin Nucl Med 23: 664-671, 1998.
13. Kricum ME. Red-yellow marrow conversion: Its effect on the location of some solitary bone lesions. Skeletal Radioln 14: 10, 1985.
14. Caner B, Kitapci M, Aras T, Erbengi G, Ugur O, Bekdik C. Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in osteosarcoma in its metastatic lymph nodes. J Nucl Med 32: 1977-1978, 1991.
15. Reiman RE, Fetters JK. Localisation of Tc-99m MIBI in diffuse myelodysplastic processes. J Nucl Med 37: 471-473, 1996.